IN VITRO AND IN VIVO ANTIANGIOGENIC EFFECT OF ARTOCARPUS HETEROPHYLLUS SEED EXTRACT

Thiruselvi M; Brindha Durairaj

doi:10.22159/ajpcr.2018.v11i9.27488

Authors

Thiruselvi M Department of Biochemistry, Dr. NGP Arts and Science College, Coimbatore, Tamil Nadu, India.
Brindha Durairaj Department of Biochemistry, PSG College of Arts and Science, Coimbatore, Tamil Nadu. India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i9.27488

Keywords:

Angiogenesis, Vascular endothelial growth factor, Human umbilical vein endothelial cells

Abstract

Objective: Angiogenesis the formation of new blood vessels from the pre-existing vasculature plays a major role in tumor growth, invasion, and metastasis of cancer diseases. The current research was designed for the inhibition of angiogenesis, which can provide a novel way to inhibit tumor growth and metastasis in cancer.

Methods: The antiangiogenic properties of serial concentrations of the hydroethanolic extract of Artocarpus heterophyllus were examined in human umbilical vein endothelial cells (HUVECs) using a tube formation assay in vitro and in a Matrigel plug assay as in vivo model.

Results: Hydroethanolic extract of A. heterophyllus significantly inhibited vascular endothelial growth factor (VEGF)-mediated angiogenesis in the HUVECs in culture dose-dependently. Further, the new blood vessel formation was observed to be inhibited by the extract at 100 mg/kg p.o. in Matrigel plug model in C57BL/6 mice. However, the effect was enhanced in higher concentration (500 mg/kg p.o.) demonstrating the in vivo antiangiogenic activity of the extract.

Conclusion: This study demonstrated that the hydroethanolic seed extract of A. heterophyllus strongly inhibited the angiogenesis in HUVECs. Moreover, the extract significantly inhibited the VEGF production in HUVECs, confirming their possible antiangiogenic mechanism.

Downloads

Download data is not yet available.

Author Biography

Thiruselvi M, Department of Biochemistry, Dr. NGP Arts and Science College, Coimbatore, Tamil Nadu, India.

Biochemistry

References

Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.

Cross MJ, Dixelius J, Matsumoto T, Claesson WL. VEGF-receptor signal transduction. Trends Biochem Sci 2003;28:488-94.

Deepika G, Sonia M, Avijit S, Gupta KR. Phytochemical, nutritional and antioxidant activity evaluation of seeds of jackfruit. Int J Pharm Bio Sci 2011;2:337-9.

Duarte M, Filho AL, Schmit FC. Angiogenesis, and cancer: New paradigms and old concerns. J Bras Patol Med Lab 2007;43:441-9.

Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646-74.

Holmes DI, Zachary I. The vascular endothelial growth factor (VEGF) family: Angiogenic factors in health and disease. Genome Biol 2005;6:209.

Jadhav J, Mane A, Kanase A. Antiangiogenic properties of Boerhaavia diffusa extracts in chick chorioallantoic membrane (CAM). Int J Drug Dev Res 2011;3:307-17.

Kato Y, Yoshimura K, Shin T, Verheul H. Hammers H. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin2 in a murine model of renal cell carcinoma. Clin Cancer Res 2007;13:4538-46.

Ravin S, Gourav CD, Anterpreet C, Reena VS. The antioxidant and anticancer activity of methanolic extract from Stephania elegans. Int J Pharm Pharm Sci 2017;9:245-9.

Kwon OS, Jeong MS, Kim B, Kim SH. Antiangiogenic effect of ethanol extract of Vigna angularis via inhibition of phosphorylation of VEGFR2. Evid Based Complement Altern Med 2015;2015:371368.

Saranya N, Thippeswamy BS, Chandrasekhar KB, Reddy ND, Kulkarni NM, Narayanan S, et al. Pharmacodynamics properties of histone deacetylase inhibitor MS-275 is enhanced in combination with phosphodiesterase inhibitor pentoxifylline in human breast cancer. Eur J Pharm 2015;764:508-19.

Jainab HN, Raja MK. In-vitro cytotoxic and apoptosis study of chemical constituents of Clerodendrum phlomidis leaf on mcf-7 breast and a-549 lung cancer cell lines. Asian J Pharm Clin Res 2018;11:209-304.

Mohan RN, Rajashekhar RN, Kaiser J. Spicy anti-cancer spices: A review. Int J Pharm Pharm Sci 2015;7:1-6.

Saka S, Singh AN, Sharma N. Potential anti-cancer superfoods: A mini review. Int J Curr Pharm Res 2016;8:19-21.

Sitohy B, Nagy JA, Dvorak HF. Anti-VEGF/VEGFR therapy for cancer: Reassessing the target. Cancer Res 2012;72:1909-14.

Kalimuthu K, Prabakaran R, Chinnadurai V. Antiangiogenic properties stem, leaf and flower extracts of Calotropis procera in chick chorioallantoic membrane (CAM). World J Pharm Pharm Sci 2014;3:777-84.

Staton CA, Reed MW, Brown NJ. A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol 2009;9:195-221.

Tosetti F, Ferrari N, De Flora S, Albini A. Angio prevention: Angiogenesis is a common and key target for cancer chemo preventive agents. FASEB J 2002;16:2-14.

Wang N, Chen L, Zhang L, Jiang R, Chen L, Shen Y. Inhibitory effect of suberoylanilide hydroxamic acid on angiogenesis and its molecular mechanism. Chin J Cell Mol Immunol 2014;30:266-9.

Zohara YB. The contribution of selected medicinal plants for cancer prevention and therapy. Sci J Fac Med 2012;29:117-23.

Abdolmaleki Z, Araba H, Amanpour S, Muhammadnejad S. Anti-angiogenic effects of ethanolic extract of Artemisia sieberi compared to its active substance, artemisinin. Braz J Pharm 2016;26:326-33.